每经AI快讯，九州通（SH 600998，收盘价：4.91元）11月24日晚间发布公告称，截至2025年11月23 日，公司控股股东楚昌投资及其一致行动人中山广银分别持有公司股份约4.6亿股和约3.35亿股，占公司 总股本的比例分别为9.11%和6.65%。本次股份提前解除质押及质押办理完成后，楚昌投资和中山广银 分别累计质押公司股份约2.34亿股和约3.2亿股，占其所持股份的比例分别为50.89%和95.33%，占公司 总股本的比例分别为4.64%和6.34%。本次股份提前解除质押及质押办理完成后，控股股东楚昌投资及 其一致行动人所持公司股份中已质押的股份总数约为12.97亿股，占其所持股份的比例为56.63%，占公 司总股本的比例为25.73%。 截至发稿，九州通市值为248亿元。 每经头条（nbdtoutiao）——大鹏工业战略配售"肥"了自家人！认购价9元，上市首日涨到118元，实控 人和亲哥哥凭配售一天浮盈2492万元 （记者 曾健辉） 2025年1至6月份，九州通的营业收入构成为：医药批发及相关业务占比95.94%，医药工业占比1.96%， 医药零售占比1.84%，医疗健康及技术服务占比0.17% ...

Group 1 - The core point of the news is that Jiuzhoutong's major shareholders, Chuchang Investment and Zhongshan Guangyin, have completed the early release and pledge of shares, with significant portions of their holdings being pledged [1] - Chuchang Investment holds approximately 460 million shares (9.11% of total shares), while Zhongshan Guangyin holds about 335 million shares (6.65% of total shares) [1] - After the pledge completion, the total number of pledged shares by the major shareholders amounts to approximately 1.077 billion shares, representing 21.37% of the company's total shares [1] Group 2 - For the first half of 2025, Jiuzhoutong's revenue composition shows that pharmaceutical wholesale and related businesses account for 95.94%, while pharmaceutical manufacturing and retail account for 1.96% and 1.84% respectively [1] - The company's current market capitalization is 25.8 billion yuan [2]

Group 1 - The company Jiuzhoutong (SH 600998) announced that its shareholder Shanghai Hongkang holds approximately 1.088 billion shares, accounting for 21.58% of the total share capital [1] - After the early release of share pledges, Shanghai Hongkang has pledged a total of approximately 467 million shares, which is 42.87% of its holdings and 9.25% of the total share capital [1] - As of September 25, 2025, the controlling shareholder Chuchang Investment and its concerted parties hold approximately 2.291 billion shares, representing 45.43% of the total share capital [1] Group 2 - Following the early release of share pledges, the total number of pledged shares held by Chuchang Investment and its concerted parties is approximately 1.077 billion shares, reducing the pledged proportion of their holdings to 47.01% and the total share capital to 21.36% [1] - For the first half of 2025, Jiuzhoutong's revenue composition is as follows: pharmaceutical wholesale and related businesses account for 95.94%, pharmaceutical manufacturing for 1.96%, pharmaceutical retail for 1.84%, medical health and technology services for 0.17%, and other businesses for 0.08% [1] - As of the report date, Jiuzhoutong's market capitalization is 24.6 billion yuan [1]